ASH ALL in AYAs Guidelines: Frontline Management

Over recent years, evolving data on outcomes and treatment related toxicity in adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL), together with variable use of pediatric- and adult-inspired regimens, have highlighted the need for careful balancing of treatment intensity and tolerability in frontline care. The purpose of these guidelines is to provide evidence-based recommendations to support treatment decision-making for AYAs with newly diagnosed ALL.

Guideline Implementation Tools and Resources

Visual Summary

This concise visual aid is intended to support understanding of the recommendations and to aid in clinical decision-making:

Teaching Slides

Educational slide sets to teach about frontline management of ALL in AYAs.

Pocket Guide

This brief, evidence-based pocket guide is intended to help physicians provide quality care to patients.

What is ALL?

Infographic to better understand ALL in AYAs, including its risks, symptoms, and treatment options